Stream this podcast to learn from experts Alexis E. Horace, PharmD, BCACP,andNimish Patel, PharmD, PhD, AAHIVP, how specialist pharmacists can overcome key barriers to care and apply best practices for optimization of antiretroviral therapy for HIV. Topics covered include:

• Leveraging pharmacists’ expertise to advance HIV treatment
• Pharmacist roles in HIV care and management
• The current ART landscape
• Regimen simplification
• Consideration of patient preferences, health factors, and comorbidities for ART optimization
• ART management for treatment-experienced patients, including those with multidrug-resistant HIV

Presenters:

Alexis E. Horace, PharmD, BCACP
Professor of Pharmacy Practice
University of Louisiana at Monroe College of Pharmacy
New Orleans Campus
CrescentCare Ambulatory Care Clinical Pharmacist, HIV Specialty
New Orleans, Louisiana

Nimish Patel, PharmD, PhD, AAHIVP
Professor of Clinical Pharmacy
Division of Clinical Pharmacy
Skaggs School of Pharmacy & Pharmaceutical Sciences
University of California, San Diego
La Jolla, California

Link to full program:
https://bit.ly/41agtqQ

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Tune in to learn how the recent FDA approval of lenacapavir (LEN) for PreP integrates into the current field of HIV prevention. Listen on the go or follow along with our expert-curated slides. Topics covered include:

• The current landscape of PrEP
• FDA approval of lenacapavir
• Phase III efficacy and safety data for lenacapavir
• Recommendations and perspectives on the future of PrEP

Presenters:

Colleen F. Kelley, MD, MPH
Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Co-Director, Emory Center for
AIDS Research
Associated Dean for Research,
Emory at Grady
Emory University School of Medicine
Atlanta, Georgia

Raphael J. Landovitz, MD, MSc
Professor of Medicine
Chief, Division of Infectious Diseases
Associate Vice Chair for
Clinical Research
Department of Medicine
David Geffen School of Medicine
University of California, Los Angeles
Director, UCLA Center for Clinical AIDS Research & Education (CARE)
Director, Center for HIV Identification, Prevention, and Treatment Services (CHIPTS)
Los Angeles, California

Link to full program:
https://bit.ly/4m8RaOg

Hear from experts in HIV care Beatriz Grinsztejn, MD, PhD, and Rosie Mnggibisa, MBChB, MPH, as they discuss their insights on some of the most clinically relevant new data presented at IAS 2025, including studies on:

• Gaps in care for adolescents and young adults living with HIV
• Global impact of funding cuts
• Antiretroviral therapy for treating HIV
• Patient management strategies for people living with HIV and obesity

Presenters:

Beatriz Grinsztejn, MD, PhD
Director
STI/HIV Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases – FIOCRUZ
Rio de Janeiro, Brazil

Rosie Mngqibisa, MBChB, MPH
Clinical Director
Principal Investigator
Enhancing Care Foundation
Durban, South Africa

Link to full program:
https://bit.ly/4otF8AR

Listen in as Dr Emily Heil explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.

Topics covered include:

• The importance of good blood culture practices and finding the balance between overuse and underuse
• Blood culture improvement programs
• The utility of rapid diagnostic tests
• Resistance markers for earlier targeted therapy

Presenters:

Emily Heil, PharmD, MS, BCIDP, AAHIVP
Professor
Department of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
Baltimore, Maryland

Link to full program:
https://bit.ly/45Ajz92

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Tune in as Dr George Behrenspresents the fundamentals on specialized agents for treatment-experienced people living with HIV.

Topics covered include:

• Key targets and mechanisms of action for specialized HIV drugs
• Clinical trial data supporting safety and efficacy of these agents
• Considerations for potential drug–drug interactions
• Strategies for leveraging these agents to construct new ART regimens for treatment-experienced individuals

Presenters:

Georg Behrens, MD
Professor of Immunology
Senior Consultant
Department of Rheumatology and Immunology
Hannover Medical School, Germany
Hannover, Germany

Link to full program:
https://bit.ly/4oiYxEx

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Dr Josep M. Llibrereviews the essentials on ART selection for treatment-experienced people with HIV and comorbidities.

Topics covered include:

• Underlying reasons for development of multidrug-resistant HIV
• Inflammation and immune activation associated with frequency of age-related conditions
• General principles for designing ART regimens for persons with multidrug-resistant HIV
• Treatment options for highly treatment‒experienced people
• Considerations for comorbidities and drug–drug interactions

Presenters:

Josep M. Llibre, MD, PhD
Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain

Link to full program:
https://bit.ly/4oiYxEx

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Tune in as Dr Daniel R. Kuritzkes presents a quick and easy primer on managing multidrug resistant HIV.

Topics covered include:

• How to recognize key populations who may present with multidrug-resistant HIV
• Identifying underlying reasons for regimen failure
• Evaluating resistance profiles
• Constructing new ART regimens for treatment-experienced individuals.

Presenters:

Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Link to full program:
https://bit.ly/4oiYxEx

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH​, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include:

• Steatotic liver disease and PBC
• Vibration-controlled transient elastography (VCTE) and discordant biochemical responses in PBC
• PPAR agonists and IBATs for PBC treatment

Presenter:

Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH
Associate Professor
NIHR Birmingham BRC
University of Birmingham
Consultant Hepatologist, Liver Unit
University Hospitals Birmingham
Birmingham, United Kingdom

Link to full program:
https://bit.ly/4lKaO2H

Follow along with the slides:
https://bit.ly/44PPBys

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.